Online Matchmaking: EP PerMed Twinning Call 2026

25 Sept 2025 – 26 Feb 2026

Register
Register
Register

ExpertiseUpdated on 17 October 2025

Provide and adapt an SEEG quantitative analysis platform

CEO at Avrio MedTech

Toulouse, France

About

Are you a hospital practicing SEEG for drug-resistant epileptic patients?

We will provide you with a Halyzia licence leveraging biomarkers of epilepsy to help delineate the epileptogenic zone during SEEG (stereo EEG).

We will work with you to do the necessary adaptation to meet your workflow and hospital requirements.

Organisation

Avrio MedTech

Company/SME

Toulouse, France

Similar opportunities

  • Expertise

    Advisory services on the implementation of 3D printing technology in public and private hospitals.

    • Donor institution with a ready PM approach
    • Receiver institution with a need to adopt a PM approach
    • Clinical decision support systems for personalised medicine
    • Full adoption/acquisition of a PM solution into clinical practice
    • Personalised treatment pathways (tailored therapies, precision dosing)
    • Patient management systems (decision-support tools, clinical workflows)
    • Partial adoption of a PM solution (testing selected modules/components)
    • Screening & early detection programs (risk stratification, predictive tools)
    • Cultural/organisational change approaches (staff training, workflow redesign)
    • Reimbursement-ready approaches (integration with public health insurance systems)
    • Adaptation of care pathways for PM (embedding new tests/therapies into routine care)
    • Patient engagement & empowerment strategies (self-management tools, shared decision-making)
    • Adaptation of an existing PM solution to local context (language, IT environment, regulations)
    • Initiating implementation of a PM solution (pilot site setup, proof-of-concept in clinical practice)

    Jesús Corbacho

    Medical Advisor on 3D Printing Integration in Clinical Environments. at Eureqa 3D

    Cáceres, Spain

  • Expertise

    Deep Learning & GenAI for Multimodal Digital Biomarkers + EU R&I Consultancy (Privacy-Preserving Clinical AI)

    • Tools for secure data sharing & secondary use (pseudonymisation, FAIR data)
    • Data integration & interoperability solutions (EHRs, registries, data platforms)
    • Implementation of CE-marked digital health solutions (AI algorithms, software, apps)

    Selay Yüksel

    Head of International Projects at ViFrameAI

    İstanbul, Türkiye

  • Expertise

    GenAI-Powered Personalised Medicine: Multimodal Digital Biomarkers & Clinician-in-the-Loop Therapy Suggestion

    Selay Yüksel

    Head of International Projects at ViFrameAI

    İstanbul, Türkiye